Caribou Biosciences (CRBU) Assets Average (2021 - 2025)
Historic Assets Average for Caribou Biosciences (CRBU) over the last 5 years, with Q3 2025 value amounting to $207.9 million.
- Caribou Biosciences' Assets Average fell 4201.82% to $207.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.9 million, marking a year-over-year decrease of 4201.82%. This contributed to the annual value of $372.8 million for FY2024, which is 750.05% down from last year.
- According to the latest figures from Q3 2025, Caribou Biosciences' Assets Average is $207.9 million, which was down 4201.82% from $247.3 million recorded in Q2 2025.
- Caribou Biosciences' Assets Average's 5-year high stood at $452.2 million during Q4 2021, with a 5-year trough of $207.9 million in Q3 2025.
- Over the past 5 years, Caribou Biosciences' median Assets Average value was $386.3 million (recorded in 2022), while the average stood at $367.0 million.
- As far as peak fluctuations go, Caribou Biosciences' Assets Average surged by 3221.26% in 2022, and later crashed by 4201.82% in 2025.
- Quarter analysis of 5 years shows Caribou Biosciences' Assets Average stood at $452.2 million in 2021, then fell by 14.57% to $386.3 million in 2022, then grew by 15.16% to $444.9 million in 2023, then decreased by 26.08% to $328.8 million in 2024, then plummeted by 36.76% to $207.9 million in 2025.
- Its Assets Average was $207.9 million in Q3 2025, compared to $247.3 million in Q2 2025 and $293.5 million in Q1 2025.